Dolby Laboratories (DLB) rated Buy with price target $61 by Maxim Group
Maxim Group rated Buy Dolby Laboratories (NYSE: DLB) on 05/06/2011, when the stock price was $48.25. Since
then, Dolby Laboratories has lost 13.26% as of 09/29/2014's recent price of $41.85. If you would have followed this Maxim Group's recommendation on DLB, you would have lost 13.26% of your investment in 1242 days.
develops and delivers products and technologies that make the entertainment experience more realistic and immersive. For nearly four decades, Dolby has been at the forefront of defining high-quality audio and surround sound in cinema, broadcast, home audio systems, cars, DVDs, headphones, games, televisions, and personal computers. Based in San Francisco with headquarters in England, the company has entertainment industry liaison offices in New York and Los Angeles, and licensing liaison offices in London, Shanghai, Beijing, Hong Kong, and Tokyo.
At Maxim Group
, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.